ATTOQUANT DIAGNOSTICS GMBH has a total of 26 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals and measurement are PUSCHETT JULES B, GLOBAL GENOMICS GROUP LLC and INST DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 5 | |
#3 | Australia | 2 | |
#4 | Brazil | 2 | |
#5 | Canada | 2 | |
#6 | EAPO (Eurasian Patent Organization) | 2 | |
#7 | Hungary | 2 | |
#8 | WIPO (World Intellectual Property Organization) | 2 | |
#9 | China | 1 | |
#10 | Hong Kong | 1 | |
#11 | New Zealand | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Poglitsch Marko | 22 |
#2 | Schwager Cornelia | 22 |
#3 | Loibner Hans | 13 |
#4 | Schuster Manfred | 10 |
#5 | Van Oyen Dunja | 9 |
#6 | Leitner Martin | 9 |
#7 | Marko Poglitsch | 2 |
#8 | Cornelia Schwager | 2 |
#9 | Martin Leitner | 1 |
#10 | Dunja Van Oyen | 1 |
Publication | Filing date | Title |
---|---|---|
WO2015086774A1 | Compositions and methods for the treatment of diseases related to the renin-angiotensin-system | |
CA2926382A1 | Method for diagnosis of primary hyperaldosteronism | |
EP2893925A1 | Compositions and methods for the treatment of diseases related to the renin-angiotensin-system | |
EP2863228A1 | Method for diagnosis of primary hyperaldosteronism | |
NZ630182A | Method for measurement of peptidic degradation products of a proteolytic cascade in blood samples |